Zepbound tops Wegovy for weight loss in Eli Lilly study
Shares of Eli Lilly climbed early Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss ...
Zepbound: The new weight loss pill that’s set to beat Wegovy, according to Eli Lilly
Eli Lilly’s weight loss drug, Zepbound, has been shown to lead to more significant weight loss than Novo Nordisk’s Wegovy, ...
STAT3h
U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
MedPage Today5h
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says
Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...
Eli Lilly’s Weight-Loss Drug Zepbound More Effective than Novo’s Wegovy, Study Shows
New data indicating Eli Lilly’s obesity shot Zepbound works better than Novo Nordisk’s Wegovy could add fuel to Lilly’s new ...
Gen Z’s Dangerous Quest for Gains
Thanks to social media saturation and crafty supplement marketing, young boys are pushing weights and chugging shakes to get ...
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
In a press release, Lilly announced that in its latest trial comparing its medication, Zepbound, to Wegovy, made by Novo ...
WebMD16h
Women's Health Resource Center
Despite following all recommended screenings, Regina Barzilay, PhD, was diagnosed with breast cancer. Discover how this Health Hero’s experience led to an AI system that improves breast cancer ...